A carregar...
mTORC1 inhibitors: is temsirolimus in renal cancer telling us how they really work?
The proof of principle that a drug targeting mTOR can improve survival has been obtained recently from a large randomised trial using temsirolimus as a first-line therapy in patients with advanced poor prognostic renal cell carcinoma. Consistent data have recently shown the important role of the PI3...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group
2008
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2570519/ https://ncbi.nlm.nih.gov/pubmed/18797463 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6604636 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|